4
Changes in Ownership
MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0000950170-24-121722
Director sold 5,000 shares at an average $300.94 ($1,504,703)
- Director acquired 5,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Levy Richard S Director | 2024-11-01 | Option exercise 10b5-1 | +5,000 | $7.36 | $36,800 | 16,012 | D |
| Levy Richard S Director | 2024-11-01 | Sale 10b5-1 | −2,800 | $300.10 | $840,278 | 13,212 | D |
| Levy Richard S Director | 2024-11-01 | Sale 10b5-1 | −1,100 | $301.22 | $331,339 | 12,112 | D |
| Levy Richard S Director | 2024-11-01 | Sale 10b5-1 | −800 | $302.25 | $241,799 | 11,312 | D |
| Levy Richard S Director | 2024-11-01 | Sale 10b5-1 | −300 | $304.29 | $91,287 | 11,012 | D |
| Derivatives | |||||||
| Levy Richard S Director | 2024-11-01 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,000 | 10,000 | D | ||
| Open-market sales · 5,000 sh · avg $300.94 · $1,504,703 | |||||||
Loading xslF345X05/ownership.xml…